← Back to Search

Brachytherapy

IORT for Glioblastoma Recurrence

N/A
Waitlist Available
Led By David A Wiles, MD
Research Sponsored by Parkridge Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up overall survival (os) will be defined as the interval from enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to three years.
Awards & highlights

Study Summary

This trial assesses whether a new, single-fraction radiation treatment is as good as the standard radiation treatment for people with a type of brain cancer that has come back.

Eligible Conditions
  • Glioblastoma Multiforme (GBM)
  • Glioblastoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~overall survival (os) will be defined as the interval from enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to three years.
This trial's timeline: 3 weeks for screening, Varies for treatment, and overall survival (os) will be defined as the interval from enrollment until the date of first documented progression or date of death from any cause, whichever came first, assessed up to three years. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Medical Devices
The primary endpoint is Overall Survival (OS)
Secondary outcome measures
Karnofsky Performance Status (KPS)
Local Progression-free Survival (PFS)
Quality of Life Assessment (Fact-Br)
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intra-operative Radiation Therapy - IORTExperimental Treatment1 Intervention
Intra-operative Radiation Therapy - IORT

Find a Location

Who is running the clinical trial?

Parkridge Medical CenterLead Sponsor
David A Wiles, MDPrincipal InvestigatorParkridge Medical Center - Neurosurgery

Media Library

Xoft Axxent eBx System (Brachytherapy) Clinical Trial Eligibility Overview. Trial Name: NCT04763031 — N/A
Glioblastoma Research Study Groups: Intra-operative Radiation Therapy - IORT
Glioblastoma Clinical Trial 2023: Xoft Axxent eBx System Highlights & Side Effects. Trial Name: NCT04763031 — N/A
Xoft Axxent eBx System (Brachytherapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04763031 — N/A
~0 spots leftby Jun 2025